LeonaBio, Inc. (LONA)
Nasdaq: LONA · Biological Products, (No Diagnostic Substances) · Bothell, WA · filing with the SEC since 2014
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 31, 2026 | Feb 27, 2025 | Feb 22, 2024 | Mar 23, 2023 | Mar 28, 2022 | Mar 25, 2021 | · |
| Research and development | 17,500 | 70,682 | 93,790 | 61,464 | 42,794 | 13,286 | 3,793 |
| General and administrative | 16,678 | 26,093 | 33,304 | 32,552 | 21,228 | 6,709 | 1,656 |
| Total costs and expenses | 102,266 | 100,902 | 125,466 | 104,016 | 64,022 | 19,995 | 5,449 |
| Operating income | -102,266 | -100,902 | -125,466 | -104,016 | -64,022 | -19,995 | -5,449 |
| Interest expense | · | · | · | · | 3 | 367 | 346 |
| Other income (expense), net | 1,236 | 3,962 | 7,637 | 3,216 | 334 | -1,281 | -466 |
| Total non-operating income (expense) | · | · | · | · | 334 | -1,281 | -466 |
| Income before income taxes | · | · | · | · | · | -19,955 | -5,161 |
| Income tax expense | 0 | · | · | · | · | · | · |
| Net income including non-controlling interests | -105,609 | -96,940 | -117,672 | -95,639 | -54,853 | -19,955 | -5,161 |
| Net income | -105,609 | -96,940 | -117,672 | -95,639 | -54,853 | -19,955 | -5,161 |
| Earnings per share, basic | -24.70 | -25.19r | -30.90b | -25.30b | -14.90b | · | · |
| Earnings per share, diluted | -24.70 | -25.19r | -30.90b | -25.30b | -14.90b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -14.90b | -16.70b | -14.50b |
| Weighted average shares, basic | 4,275,762 | 3,848,044r | 3,802,018b | 3,773,324b | 3,692,117b | · | · |
| Weighted average shares, diluted | 4,275,762 | 3,848,044r | 3,802,018b | 3,773,324b | 3,692,117b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 3,692,117b | 1,196,691b | 356,685b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-10 reverse split of Dec 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted